YU71500A - Metod za dobijanje 4-karboksiamino-2-supstituisanog -1,2,3,4-tetrahidrohinolina - Google Patents

Metod za dobijanje 4-karboksiamino-2-supstituisanog -1,2,3,4-tetrahidrohinolina

Info

Publication number
YU71500A
YU71500A YU71500A YUP71500A YU71500A YU 71500 A YU71500 A YU 71500A YU 71500 A YU71500 A YU 71500A YU P71500 A YUP71500 A YU P71500A YU 71500 A YU71500 A YU 71500A
Authority
YU
Yugoslavia
Prior art keywords
quinoline
making
carboxyamino
tetrahydro
substituted
Prior art date
Application number
YU71500A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
David Burns Damon
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU71500A publication Critical patent/YU71500A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU71500A 1999-11-30 2000-11-16 Metod za dobijanje 4-karboksiamino-2-supstituisanog -1,2,3,4-tetrahidrohinolina YU71500A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16796799P 1999-11-30 1999-11-30

Publications (1)

Publication Number Publication Date
YU71500A true YU71500A (sh) 2003-02-28

Family

ID=22609556

Family Applications (1)

Application Number Title Priority Date Filing Date
YU71500A YU71500A (sh) 1999-11-30 2000-11-16 Metod za dobijanje 4-karboksiamino-2-supstituisanog -1,2,3,4-tetrahidrohinolina

Country Status (44)

Country Link
US (1) US6313142B1 (forum.php)
EP (1) EP1125929B1 (forum.php)
JP (1) JP3579345B2 (forum.php)
KR (1) KR100408177B1 (forum.php)
CN (1) CN1173953C (forum.php)
AP (1) AP2000002011A0 (forum.php)
AR (1) AR029775A1 (forum.php)
AT (1) ATE315028T1 (forum.php)
AU (1) AU784694B2 (forum.php)
BG (1) BG105009A (forum.php)
BR (1) BR0005636A (forum.php)
CA (1) CA2327029C (forum.php)
CO (1) CO5261552A1 (forum.php)
CY (1) CY1104989T1 (forum.php)
CZ (1) CZ20004407A3 (forum.php)
DE (1) DE60025317T2 (forum.php)
DK (1) DK1125929T3 (forum.php)
DZ (1) DZ3079A1 (forum.php)
EA (1) EA003668B1 (forum.php)
EE (1) EE200000659A (forum.php)
ES (1) ES2254109T3 (forum.php)
GE (1) GEP20022798B (forum.php)
GT (1) GT200000190A (forum.php)
HN (1) HN2000000203A (forum.php)
HR (1) HRP20000804A2 (forum.php)
HU (1) HUP0004747A3 (forum.php)
ID (1) ID28489A (forum.php)
IL (1) IL139849A (forum.php)
IS (1) IS5715A (forum.php)
MA (1) MA25223A1 (forum.php)
NO (1) NO20006039L (forum.php)
NZ (1) NZ508509A (forum.php)
OA (1) OA11494A (forum.php)
PA (1) PA8503801A1 (forum.php)
PE (1) PE20010913A1 (forum.php)
PL (1) PL344208A1 (forum.php)
SG (1) SG102603A1 (forum.php)
SK (1) SK17792000A3 (forum.php)
TN (1) TNSN00230A1 (forum.php)
TW (1) TW591016B (forum.php)
UA (1) UA65615C2 (forum.php)
UY (1) UY26451A1 (forum.php)
YU (1) YU71500A (forum.php)
ZA (1) ZA200006947B (forum.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.
HUP0500165A2 (en) * 2001-12-19 2006-09-28 Atherogenics Inc Chalcone derivatives and their use to treat diseases
US7202247B2 (en) 2001-12-19 2007-04-10 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
DE60323954D1 (de) * 2002-04-11 2008-11-20 Roar Holding Llc Ex-vivo-verfahren zur bestimmung der cetp-aktivität und der wirksamkeit der behandlung von herzerkrankungen
US7504508B2 (en) * 2002-10-04 2009-03-17 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
EA011385B1 (ru) * 2002-10-04 2009-02-27 Миллениум Фармасьютикалз, Инк. Антагонисты рецептора pgd2 для лечения воспалительных заболеваний
US20090181966A1 (en) * 2002-10-04 2009-07-16 Millennium Pharmaceuticals, Inc. PGD2 receptor antagonists for the treatment of inflammatory diseases
US7223870B2 (en) * 2002-11-01 2007-05-29 Pfizer Inc. Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
US20040181075A1 (en) * 2002-12-19 2004-09-16 Weingarten M. David Process of making chalcone derivatives
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
BR0317521A (pt) 2002-12-20 2005-11-16 Pfizer Prod Inc Formas de dosagem compreendendo um inibidor da cetp e um inibidor da redutase hmg-coa
US20060100239A1 (en) * 2003-03-04 2006-05-11 Izuru Nagasaki Method for producing optically active amines
EP2289507A1 (en) * 2003-03-17 2011-03-02 Japan Tobacco, Inc. Pharmaceutical compositions of CETP inhibitors
US7276536B2 (en) * 2003-03-17 2007-10-02 Japan Tobacco Inc. Method for increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino) phenyl] 2-methylpropanethioate
TWI393560B (zh) * 2003-05-02 2013-04-21 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
EA200600737A1 (ru) * 2003-10-08 2006-10-27 Эли Лилли Энд Компани Соединения и способы для лечения дислипидемии
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
US20080269284A1 (en) * 2004-06-24 2008-10-30 Eli Lilly And Company Compounds and Methods for Treating Dyslipidemia
DOP2005000123A (es) * 2004-07-02 2011-07-15 Merck Sharp & Dohme Inhibidores de cetp
WO2006033001A1 (en) * 2004-09-23 2006-03-30 Pfizer Products Inc. Quinoline compounds
WO2006069162A1 (en) * 2004-12-20 2006-06-29 Reddy Us Therapeutics, Inc. Novel heterocyclic compounds and their pharmaceutical compositions
MX2007010215A (es) * 2005-02-24 2007-11-07 Millennium Pharm Inc Antagonistas del receptor pgd2 para el tratamiento de enfermedades inflamatorias.
UY30244A1 (es) 2006-03-30 2007-11-30 Tanabe Seiyaku Co Un proceso para preparar derivados de tetrahidroquinolina
CL2008000684A1 (es) 2007-03-09 2008-08-01 Indigene Pharmaceuticals Inc Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica.
CN101429160B (zh) * 2007-11-06 2011-10-19 上海药明康德新药开发有限公司 一种1-r-4-氨基-1,2,3,4-四氢喹啉的合成方法
AR077208A1 (es) * 2009-06-30 2011-08-10 Lilly Co Eli Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam
US12006305B2 (en) 2022-07-05 2024-06-11 Newamsterdam Pharma B.V. Salts of obicetrapib and processes for their manufacture and intermediates thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7870M (forum.php) * 1968-11-08 1970-04-27
US3971789A (en) 1972-10-21 1976-07-27 John Wyeth & Brother Limited O-(4-Quinolylamino)benzamides
GB8432091D0 (en) 1984-12-19 1985-01-30 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US4839368A (en) 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
GB8804444D0 (en) 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
US5231102A (en) 1989-03-08 1993-07-27 Merck Sharp & Dohme, Ltd. Tetrahydroquinoline derivatives useful for neurodegenerative disorders
PT100905A (pt) * 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6140342A (en) 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
HN2000000203A (es) * 1999-11-30 2001-06-13 Pfizer Prod Inc Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas.

Also Published As

Publication number Publication date
SG102603A1 (en) 2004-03-26
PE20010913A1 (es) 2001-09-10
AR029775A1 (es) 2003-07-16
HN2000000203A (es) 2001-06-13
IL139849A (en) 2006-10-31
HUP0004747A2 (hu) 2001-10-28
KR100408177B1 (ko) 2003-12-01
CY1104989T1 (el) 2010-03-03
IS5715A (is) 2001-05-31
HRP20000804A2 (en) 2001-06-30
DE60025317T2 (de) 2006-08-03
HU0004747D0 (forum.php) 2001-02-28
TNSN00230A1 (fr) 2005-11-10
CZ20004407A3 (cs) 2002-06-12
AP2000002011A0 (en) 2000-12-31
PA8503801A1 (es) 2002-07-30
DE60025317D1 (de) 2006-03-30
EP1125929B1 (en) 2006-01-04
CA2327029C (en) 2005-08-09
JP2001163859A (ja) 2001-06-19
CA2327029A1 (en) 2001-05-30
GEP20022798B (en) 2002-09-25
CN1173953C (zh) 2004-11-03
EA003668B1 (ru) 2003-08-28
ATE315028T1 (de) 2006-02-15
EA200001129A3 (ru) 2001-10-22
NO20006039D0 (no) 2000-11-29
EE200000659A (et) 2001-08-15
CN1302800A (zh) 2001-07-11
KR20010052012A (ko) 2001-06-25
UY26451A1 (es) 2001-06-29
EP1125929A1 (en) 2001-08-22
AU784694B2 (en) 2006-06-01
BG105009A (en) 2001-11-30
GT200000190A (es) 2002-04-27
IL139849A0 (en) 2002-02-10
BR0005636A (pt) 2001-07-17
MA25223A1 (fr) 2001-07-02
ZA200006947B (en) 2002-05-27
SK17792000A3 (sk) 2002-10-08
OA11494A (en) 2004-05-07
DZ3079A1 (fr) 2004-10-24
CO5261552A1 (es) 2003-03-31
DK1125929T3 (da) 2006-04-03
AU7178900A (en) 2001-05-31
NO20006039L (no) 2001-05-31
UA65615C2 (uk) 2004-04-15
TW591016B (en) 2004-06-11
ID28489A (id) 2001-05-31
HUP0004747A3 (en) 2002-12-28
ES2254109T3 (es) 2006-06-16
EA200001129A2 (ru) 2001-06-25
NZ508509A (en) 2001-06-29
US6313142B1 (en) 2001-11-06
JP3579345B2 (ja) 2004-10-20
PL344208A1 (en) 2001-06-04
HK1038007A1 (en) 2002-03-01

Similar Documents

Publication Publication Date Title
YU71500A (sh) Metod za dobijanje 4-karboksiamino-2-supstituisanog -1,2,3,4-tetrahidrohinolina
AU2482800A (en) Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
TNSN01108A1 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
WO1999047497A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2000045799A3 (de) Verwendung von substituierten isoxazolcarbonsäuren und derivaten und neue stoffe
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
CA2473991A1 (en) Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
AU1831000A (en) Method of treating chronic obstructive pulmonary disease
EP0664289A3 (en) Isoquinolines
IL152778A0 (en) Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
WO1999006397A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
ATE409693T1 (de) Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure
AU1769597A (en) Morphine and diamorphine salts of anionic non-narcotic analgesics of the type substituted carboxylic acid, processes for their production, their use, and pharmaceutical preparations comprising these salts
WO2001019819A3 (en) Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
AU6557800A (en) Process for the preparation of substituted 3-phenyl-propanoic acid esters and substituted 3-phenyl-propanoic acids
RO115802B1 (ro) Derivaţi ai acidului pirazol dihidrobenzofuranil propenoic, intermediar pentru prepararea acestora, compoziţii farmaceutice ale acestora şi metodă de tratament
WO2004039453A3 (de) 7h-dibenzo[b,g][1,5]dioxocin-5-on-derivate und ihre verwendung
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.
AU4174496A (en) Silylation process
YU35599A (sh) Postupak za dobijanje hinolona i naftiridona karboksilnih kiselina
WO2000073274A3 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren
BG105618A (en) Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists
MXPA03002047A (es) Fenilciclohexanocarboxamidas substituidas y su uso.
WO2006007881A3 (en) New pharmaceutical compositions based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins
PL342415A1 (en) Novel alkyl esters of (2-ethylidene-6,6-dimethylbicyclo[3.2.0]hex-3-yl)acetic acid and method of obtaining them